期刊
EXPERT OPINION ON DRUG DELIVERY
卷 15, 期 8, 页码 821-834出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/17425247.2018.1502267
关键词
Aerosol devices; inhaled macromolecules; lung delivery; microcarrier; nanocarrier; nanomedicine; lipid-based systems; passive and active targeting; pulmonary pathologies
资金
- Medical Research Council [MR/P022758/1]
- MRC [MR/P022758/1] Funding Source: UKRI
Introduction: Macromolecules with unique effects and potency are increasingly being considered for application in lung pathologies. Numerous delivery strategies for these macromolecules through the lung have been investigated to improve the targeting and overall efficacy.Areas covered: Targeting approaches from delivery devices, formulation strategies and specific targets are discussed.Expert opinion: Although macromolecules are a heterogeneous group of molecules, a number of strategies have been investigated at the macro, micro, and nanoscopic scale for the delivery of macromolecules to specific sites and cells of lung tissues. Targeted approaches are already in use at the macroscopic scale through inhalation devices and formulations, but targeting strategies at the micro and nanoscopic scale are still in the laboratory stage. The combination of controlling lung deposition and targeting after deposition, through a combination of targeting strategies could be the future direction for the treatment of lung pathologies through the pulmonary route.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据